Johnson & Johnson
Johnson & Johnson News
J&J implants: Congress leader Anand Sharma seeks tougher norms for pharma majors
Speaking in the Rajya Sabha, Sharma noted that Johnson & Johnson had, in the US, agreed to pay over $1 billion as compensation and suggested that such firms were escaping responsibilities in India.
Pinnacle safe, will keep you posted: Johnson & Johnson told Govt in 2011, went silent
Johnson & Johnson has claimed that there are no patients with adverse reports in India. As reported today, The Indian Express tracked down down eight patients, five men and three women, who had the Pinnacle implanted.
Advertising
Johnson & Johnson says no suffering patients in India. Meet some of them
Investigating the patients' records paints a story of suffering, neglect and indifference. Of them hitting a wall when it comes to seeking justice even as they fight debilitating pain, organ damage, pseudo-tumours, the toxic effects of excess cobalt-chromium in the blood.
In US, Johnson & Johnson agrees to pay $1 billion for faulty hip implants, in India brazens it out
Johnson & Johnson has claimed in India that it has received no adverse event reports on Pinnacle. Medical records accessed by The Indian Express show otherwise.
Patient groups urge HealthMin to ‘discontinue’ J&J TB drug donations
J&J, earlier this month, announced that it would be providing 10,000 courses of bedaquiline, used to treat multi drug-resistant TB, “free of charge” to India through USAID in addition to the 10,000 courses it had committed before.
Johnson & Johnson's rejects lab report on baby shampoo, authorities want product off shelves
The company has strongly objected to the Jaipur-based Drug Testing Laboratory's findings that declared the shampoo allegedly contained formaldehyde.
Advertising
J&J baby care products: NCPCR summons officials of five states
Last month, Johnson & Johnson, had come under the scanner after the Rajasthan drugs control organisation red flagged two batches of the company’s baby shampoo for failing quality tests.
J&J baby shampoo samples fail quality test; company rejects findings
The Rajasthan Drugs Control Organisation's notice dated March 5 said that the samples of J&J's baby shampoo taken from two batches had failed the quality test as they contained "harmful ingredients".
California jury orders Johnson & Johnson to pay $29 million in latest talc cancer trial
The verdict, in California Superior Court in Oakland, marks the latest defeat for the healthcare conglomerate, which faces more than 13,000 talc-related lawsuits nationwide.
Pay Rs 74.5 lakh to patient with ‘faulty’ hip implant: Drug regulator tells Johnson & Johnson
Johnson & Johnson had marketed the ASR (articular surface replacement) implants in India through its subsidiary DePuy between 2004 and 2010.
Johnson & Johnson Videos
How Johnson & Johnson pushed another 'faulty' hip implant in India
What slipped under the radar is a story of how Johnson & Johnson used a loophole in US laws to push the product into the Indian market.
Advertising